(44) described that thrombomodulin degraded HMGB1, which inhibited NET induction, thereby preventing pancreatic cancer metastasis to the liver, and blocked EMT and attenuated the malignant potential of pancreatic cancer cells. The gene discussed is HMGB1; the disease is pancreatic neoplasm.